Banco Bilbao Vizcaya Argentaria S.A. Has $14.18 Million Stock Position in Danaher Corporation $DHR

Banco Bilbao Vizcaya Argentaria S.A. grew its stake in Danaher Corporation (NYSE:DHR) by 63.0% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 72,032 shares of the conglomerate’s stock after buying an additional 27,834 shares during the quarter. Banco Bilbao Vizcaya Argentaria S.A.’s holdings in Danaher were worth $14,176,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in DHR. California Public Employees Retirement System increased its holdings in Danaher by 29.6% during the 3rd quarter. California Public Employees Retirement System now owns 1,771,851 shares of the conglomerate’s stock worth $351,287,000 after purchasing an additional 404,719 shares in the last quarter. Chilton Investment Co. Inc. lifted its holdings in shares of Danaher by 15.0% in the third quarter. Chilton Investment Co. Inc. now owns 3,229 shares of the conglomerate’s stock valued at $640,000 after purchasing an additional 422 shares in the last quarter. Chiron Capital Management LLC boosted its position in shares of Danaher by 2.4% during the third quarter. Chiron Capital Management LLC now owns 4,303 shares of the conglomerate’s stock worth $853,000 after buying an additional 101 shares during the period. Boothbay Fund Management LLC boosted its position in shares of Danaher by 543.7% during the third quarter. Boothbay Fund Management LLC now owns 7,988 shares of the conglomerate’s stock worth $1,584,000 after buying an additional 6,747 shares during the period. Finally, Aquatic Capital Management LLC grew its holdings in shares of Danaher by 1.7% during the third quarter. Aquatic Capital Management LLC now owns 144,255 shares of the conglomerate’s stock worth $28,600,000 after buying an additional 2,474 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Danaher Trading Up 0.6%

NYSE DHR opened at $187.34 on Monday. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $242.80. The company has a current ratio of 1.87, a quick ratio of 1.51 and a debt-to-equity ratio of 0.35. The stock has a 50 day moving average of $218.79 and a 200-day moving average of $215.48. The company has a market cap of $132.47 billion, a PE ratio of 37.17, a PEG ratio of 2.54 and a beta of 0.93.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share for the quarter, topping analysts’ consensus estimates of $2.14 by $0.09. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The business had revenue of $6.84 billion for the quarter, compared to the consensus estimate of $6.79 billion. During the same period in the previous year, the company earned $2.14 earnings per share. The firm’s revenue for the quarter was up 4.6% on a year-over-year basis. On average, equities research analysts anticipate that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Friday, March 27th will be paid a dividend of $0.40 per share. The ex-dividend date is Friday, March 27th. This represents a $1.60 annualized dividend and a dividend yield of 0.9%. This is a boost from Danaher’s previous quarterly dividend of $0.32. Danaher’s dividend payout ratio (DPR) is presently 25.40%.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the company. Morgan Stanley assumed coverage on Danaher in a research note on Monday, December 1st. They issued an “overweight” rating and a $270.00 target price on the stock. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Danaher in a research note on Thursday, January 29th. Weiss Ratings reissued a “hold (c)” rating on shares of Danaher in a research report on Monday, December 29th. JPMorgan Chase & Co. raised their target price on shares of Danaher from $270.00 to $275.00 and gave the company an “overweight” rating in a research report on Thursday, January 29th. Finally, TD Cowen reissued a “buy” rating on shares of Danaher in a research report on Wednesday, January 7th. Nineteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $253.55.

Insider Activity

In related news, EVP Gregory M. Milosevich sold 1,320 shares of the firm’s stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $208.01, for a total value of $274,573.20. Following the completion of the sale, the executive vice president directly owned 5,099 shares in the company, valued at approximately $1,060,642.99. This trade represents a 20.56% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 11.20% of the company’s stock.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.